https://www.clinicaltrialsarena.com/analyst-comment/caladrius-biosciences-cmd/
Caladrius Biosciences initiates Phase IIb for CLBS16 in CMD
Feb 12, 2021 - Caladrius Biosciences has announced initiation of its Phase IIb FREEDOM trial evaluating the efficacy and safety of CLBS16 as CMD treatment.
caladrius biosciencesphase iibinitiatescmd